Evidence map›Paper›PMID 41639698›Full record

Observational studyInfectious diseases of poverty2026

Clinical and epidemiological features of schistosomiasis among sub-Saharan African migrants in Barcelona, Spain: a retrospective observational study.

Derlis Duarte-Zoilan, Fernando Salvador, Cristina Bocanegra, Elena Sulleiro, Adrián Sánchez-Montalvá, Núria Serre-Delcor, Pau Bosch-Nicolau, María Luisa Aznar, Lidia Goterris, Diana Pou and 7 more

Abstract readObservational Study
In one paragraph

Observational study in Infectious diseases of poverty, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Derlis Duarte-ZoilanDepartment of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
Fernando SalvadorDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain. fernando.salvador@vallhebron.cat.
Cristina BocanegraDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Elena SulleiroBiomedical Research Networking Center for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.
Adrián Sánchez-MontalváDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Núria Serre-DelcorDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Pau Bosch-NicolauDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
María Luisa AznarDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Lidia GoterrisBiomedical Research Networking Center for Infectious Diseases (CIBERINFEC), Carlos III Health Institute, Madrid, Spain.
Diana PouDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
María EspiauUnit of Pediatric Infectious Diseases and Immunodeficiencies, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Patricia Martínez-VallejoDepartment of Microbiology, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Joan Martínez-CampreciósDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Juan Espinosa-PereiroDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Inés OliveiraDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.
Francesc ZarzuelaDepartment of Microbiology, Vall d'Hebron University Hospital, PROSICS Barcelona, Barcelona, Spain.
Israel MolinaDepartment of Infectious Diseases, Unit of International Health Vall d'Hebron-Drassanes, Vall d'Hebron University Hospital, PROSICS Barcelona, Pº Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Schistosomiasis is a neglected tropical disease, affecting 253 million people worldwide. This study aimed to describe the clinical and epidemiological characteristics of schistosomiasis in sub-Saharan African migrants evaluated through a general screening program for imported infectious diseases at a specialized international health unit in Barcelona, Spain. We performed a retrospective observational study (2014-2023) including confirmed (defined by egg detection in stool or urine) and probable cases (identified by positive serology against Schistosoma). Data on epidemiology, clinical presentation, diagnosis, treatment, and follow-up were collected. Among 3214 screened migrants, 855 (26.6%) were diagnosed with schistosomiasis. Most were male (87%) with a median age of 21.9 years, mainly originating from Mali, Gambia, and Senegal. Only 2.2% reported symptoms, while anemia and eosinophilia were observed in 9.7% and 29.7% of cases, respectively. Parasitological confirmation was achieved in 24.9%, with the remainder diagnosed by serology alone. Abdominal ultrasound was performed in 122 patients, revealing abnormalities in 20.4%. Multivariate analysis showed that confirmed cases tended to be younger (22.4 years vs 25.8 years) and had higher frequencies of women (17.8% vs 11.3%), symptoms (5.6% vs 1.1%), eosinophilia (49.4% vs 22.5%), and ultrasound abnormalities (22.7% vs 17.8%) than probable cases. Praziquantel treatment was administered to 775 patients (90.6%). Follow-up information was available for 218 individuals (28.1%); among those, eggs persisted in 7.4% (9/122), and 84% (74/88) maintained positive serology. Schistosomiasis prevalence in this migrant population was high and mostly asymptomatic, with limited laboratory abnormalities but notable radiological findings, particularly in confirmed cases. Serology was useful diagnostically but had limited value in follow-up. Systematic screening of at-risk populations remains crucial for early detection and treatment.

Indexed as

SchistosomiasisTransients and MigrantsAdolescentAdultAfrica South of the SaharaAnimalsAnthelminticsChildFemaleHumansMaleMiddle AgedPraziquantelRetrospective StudiesSchistosomaSpainAnthelminticsPraziquantelMigrantPraziquantelSchistosomiasisSerologySub-Saharan Africa

Identifiers

PMID41639698
PMCPMC12875035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.